Nevirapine News and Research

RSS
Boehringer Ingelheim's BI 201335 new data against HCV highlighted at EASL meeting

Boehringer Ingelheim's BI 201335 new data against HCV highlighted at EASL meeting

HIV prevention, treatment highlighted at Conference on Retroviruses and Opportunistic Infections

HIV prevention, treatment highlighted at Conference on Retroviruses and Opportunistic Infections

Pediatrician unveils latest findings of IMPAACT HIV/AIDS study during 2011 CROI

Pediatrician unveils latest findings of IMPAACT HIV/AIDS study during 2011 CROI

Nevirapine reduces HIV transmission risk from mother to breastfeeding infants by 75%

Nevirapine reduces HIV transmission risk from mother to breastfeeding infants by 75%

New research: HIV-infected youth get pregnant more often, suffer complications frequently

New research: HIV-infected youth get pregnant more often, suffer complications frequently

New finding sheds light on how HIV eludes treatment by mutating

New finding sheds light on how HIV eludes treatment by mutating

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Boehringer to present data of SOUND-C1 Phase Ib study for HCV treatment at AASLD Meeting

Boehringer to present data of SOUND-C1 Phase Ib study for HCV treatment at AASLD Meeting

Phase III study influences WHO to change guidelines for HIV-infected women receiving nevirapine

Phase III study influences WHO to change guidelines for HIV-infected women receiving nevirapine

Report shows continuing progress in scaling up global HIV/AIDS interventions

Report shows continuing progress in scaling up global HIV/AIDS interventions

European Commission approves SmPC update for VIRAMUNE in HIV treatment

European Commission approves SmPC update for VIRAMUNE in HIV treatment

Switching from protease inhibitors to Nevirapine brings superior results for some HIV-infected children

Switching from protease inhibitors to Nevirapine brings superior results for some HIV-infected children

Switching to nevirapine drug from PI based regimen reduces viremia in children: Study

Switching to nevirapine drug from PI based regimen reduces viremia in children: Study

VBDS secondary to nevirapine use in HIV-positive, pregnant female: Report

VBDS secondary to nevirapine use in HIV-positive, pregnant female: Report

Boehringer Ingelheim's VERxVE study of nevirapine meets primary endpoint

Boehringer Ingelheim's VERxVE study of nevirapine meets primary endpoint

Current myths vs. realities in global AIDS funding

Current myths vs. realities in global AIDS funding

AIDS 2010 studies, releases: PMTCT, treating children, male circumcision; National prevention programs; IDUs

AIDS 2010 studies, releases: PMTCT, treating children, male circumcision; National prevention programs; IDUs

HIV – Rising menace

HIV – Rising menace

Only 51% of HIV-exposed infants received minimal dose of prevention drug nevirapine: Study

Only 51% of HIV-exposed infants received minimal dose of prevention drug nevirapine: Study

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference